- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this latest study, the 2020 growth of Immuno-Oncology will have significant change from previous year. By the most conservative estimates of global Immuno-Oncology market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 31750 million in 2019. Over the next five years the Immuno-Oncology market will register a 15.5% CAGR in terms of revenue, the global market size will reach US$ 56450 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-Oncology market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Drugstores
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Immuno-Oncology Market Size 2016-2026
2.1.2 Immuno-Oncology Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Immuno-Oncology Segment by Type
2.2.1 Immune Checkpoint Inhibitors
2.2.2 Immune Checkpoint Inhibitors
2.2.3 Cancer Vaccines
2.2.4 CAR-T Cell Therapy
2.2.5 Others
2.3 Immuno-Oncology Market Size by Type
2.3.1 Global Immuno-Oncology Market Size CAGR by Type
2.3.2 Global Immuno-Oncology Market Size Market Share by Type (2016-2021)
2.4 Immuno-Oncology Segment by Application
2.4.1 Hospitals
2.4.2 Drugstores
2.4.3 Others
2.5 Immuno-Oncology Market Size by Application
2.5.1 Global Immuno-Oncology Market Size CAGR by Application
2.5.2 Global Immuno-Oncology Market Size Market Share by Application (2016-2021)
3 Global Immuno-Oncology by Players
3.1 Immuno-Oncology Market Size Market Share by Players
3.1.1 Global Immuno-Oncology Revenue by Players (2019-2021E)
3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2019-2021E)
3.2 Global Immuno-Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Immuno-Oncology by Regions
4.1 Immuno-Oncology Market Size by Regions (2016-2021)
4.2 Americas Immuno-Oncology Market Size Growth (2016-2021)
4.3 APAC Immuno-Oncology Market Size Growth (2016-2021)
4.4 Europe Immuno-Oncology Market Size Growth (2016-2021)
4.5 Middle East & Africa Immuno-Oncology Market Size Growth (2016-2021)
5 Americas
5.1 Americas Immuno-Oncology Market Size by Country (2016-2021)
5.2 Americas Immuno-Oncology Market Size by Type (2016-2021)
5.3 Americas Immuno-Oncology Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immuno-Oncology Market Size by Region (2016-2021)
6.2 APAC Immuno-Oncology Market Size by Type (2016-2021)
6.3 APAC Immuno-Oncology Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Immuno-Oncology by Country (2016-2021)
7.2 Europe Immuno-Oncology Market Size by Type (2016-2021)
7.3 Europe Immuno-Oncology Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Immuno-Oncology by Region (2016-2021)
8.2 Middle East & Africa Immuno-Oncology Market Size by Type (2016-2021)
8.3 Middle East & Africa Immuno-Oncology Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Immuno-Oncology Market Forecast
10.1 Global Immuno-Oncology Forecast by Regions (2021-2026)
10.1.1 Global Immuno-Oncology Forecast by Regions (2021-2026)
10.1.2 Americas Immuno-Oncology Forecast
10.1.3 APAC Immuno-Oncology Forecast
10.1.4 Europe Immuno-Oncology Forecast
10.1.5 Middle East & Africa Immuno-Oncology Forecast
10.2 Americas Immuno-Oncology Forecast by Countries (2021-2026)
10.2.1 United States Immuno-Oncology Market Forecast
10.2.2 Canada Immuno-Oncology Market Forecast
10.2.3 Mexico Immuno-Oncology Market Forecast
10.2.4 Brazil Immuno-Oncology Market Forecast
10.3 APAC Immuno-Oncology Forecast by Region (2021-2026)
10.3.1 China Immuno-Oncology Market Forecast
10.3.2 Japan Immuno-Oncology Market Forecast
10.3.3 Korea Immuno-Oncology Market Forecast
10.3.4 Southeast Asia Immuno-Oncology Market Forecast
10.3.5 India Immuno-Oncology Market Forecast
10.3.6 Australia Immuno-Oncology Market Forecast
10.4 Europe Immuno-Oncology Forecast by Country (2021-2026)
10.4.1 Germany Immuno-Oncology Market Forecast
10.4.2 France Immuno-Oncology Market Forecast
10.4.3 UK Immuno-Oncology Market Forecast
10.4.4 Italy Immuno-Oncology Market Forecast
10.4.5 Russia Immuno-Oncology Market Forecast
10.5 Middle East & Africa Immuno-Oncology Forecast by Region (2021-2026)
10.5.1 Egypt Immuno-Oncology Market Forecast
10.5.2 South Africa Immuno-Oncology Market Forecast
10.5.3 Israel Immuno-Oncology Market Forecast
10.5.4 Turkey Immuno-Oncology Market Forecast
10.5.5 GCC Countries Immuno-Oncology Market Forecast
10.6 Global Immuno-Oncology Forecast by Type (2021-2026)
10.8 Global Immuno-Oncology Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Immuno-Oncology Product Offered
11.1.3 Bristol-Myers Squibb Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Bristol-Myers Squibb Main Business Overview
11.1.5 Bristol-Myers Squibb Latest Developments
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Information
11.2.2 Merck & Co., Inc. Immuno-Oncology Product Offered
11.2.3 Merck & Co., Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Merck & Co., Inc. Main Business Overview
11.2.5 Merck & Co., Inc. Latest Developments
11.3 Roche AG
11.3.1 Roche AG Company Information
11.3.2 Roche AG Immuno-Oncology Product Offered
11.3.3 Roche AG Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Roche AG Main Business Overview
11.3.5 Roche AG Latest Developments
11.4 AstraZeneca, Plc
11.4.1 AstraZeneca, Plc Company Information
11.4.2 AstraZeneca, Plc Immuno-Oncology Product Offered
11.4.3 AstraZeneca, Plc Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 AstraZeneca, Plc Main Business Overview
11.4.5 AstraZeneca, Plc Latest Developments
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Information
11.5.2 Sanofi S.A. Immuno-Oncology Product Offered
11.5.3 Sanofi S.A. Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Sanofi S.A. Main Business Overview
11.5.5 Sanofi S.A. Latest Developments
11.6 Dendreon Pharmaceuticals
11.6.1 Dendreon Pharmaceuticals Company Information
11.6.2 Dendreon Pharmaceuticals Immuno-Oncology Product Offered
11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Dendreon Pharmaceuticals Main Business Overview
11.6.5 Dendreon Pharmaceuticals Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Immuno-Oncology Product Offered
11.7.3 Novartis Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Gilead Sciences Inc.
11.8.1 Gilead Sciences Inc. Company Information
11.8.2 Gilead Sciences Inc. Immuno-Oncology Product Offered
11.8.3 Gilead Sciences Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Gilead Sciences Inc. Main Business Overview
11.8.5 Gilead Sciences Inc. Latest Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Information
11.9.2 Merck KGaA Immuno-Oncology Product Offered
11.9.3 Merck KGaA Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Merck KGaA Main Business Overview
11.9.5 Merck KGaA Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Immuno-Oncology Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Immune Checkpoint Inhibitors
Table 3. Major Players of Cytokine-Based Immunotherapy
Table 4. Major Players of Cancer Vaccines
Table 5. Major Players of CAR-T Cell Therapy
Table 6. Major Players of Others
Table 7. Immuno-Oncology Market Size CAGR by Type (2016-2021) & ($ Millions)
Table 8. Global Immuno-Oncology Market Size by Type (2016-2021) & ($ Millions)
Table 9. Global Immuno-Oncology Market Size Market Share by Type (2016-2021)
Table 10. Immuno-Oncology Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 11. Global Immuno-Oncology Market Size by Application (2016-2021) & ($ Millions)
Table 12. Global Immuno-Oncology Market Size Market Share by Application (2016-2021)
Table 13. Global Immuno-Oncology Revenue by Players (2019-2021E) & ($ Millions)
Table 14. Global Immuno-Oncology Revenue Market Share by Players (2019-2021E)
Table 15. Global Immuno-Oncology Key Players Head office and Products Offered
Table 16. Immuno-Oncology Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Immuno-Oncology Market Size by Regions 2016-2021 & ($ Millions)
Table 20. Global Immuno-Oncology Market Size Market Share by Regions 2016-2021
Table 21. Americas Immuno-Oncology Market Size by Country (2016-2021) & ($ Millions)
Table 22. Americas Immuno-Oncology Market Size Market Share by Country (2016-2021)
Table 23. Americas Immuno-Oncology Market Size by Type (2016-2021) & ($ Millions)
Table 24. Americas Immuno-Oncology Market Size Market Share by Type (2016-2021)
Table 25. Americas Immuno-Oncology Market Size by Application (2016-2021) & ($ Millions)
Table 26. Americas Immuno-Oncology Market Size Market Share by Application (2016-2021)
Table 27. APAC Immuno-Oncology Market Size by Region (2016-2021) & ($ Millions)
Table 28. APAC Immuno-Oncology Market Size Market Share by Region (2016-2021)
Table 29. APAC Immuno-Oncology Market Size by Type (2016-2021) & ($ Millions)
Table 30. APAC Immuno-Oncology Market Size Market Share by Type (2016-2021)
Table 31. APAC Immuno-Oncology Market Size by Application (2016-2021) & ($ Millions)
Table 32. APAC Immuno-Oncology Market Size Market Share by Application (2016-2021)
Table 33. Europe Immuno-Oncology Market Size by Country (2016-2021) & ($ Millions)
Table 34. Europe Immuno-Oncology Market Size Market Share by Country (2016-2021)
Table 35. Europe Immuno-Oncology Market Size by Type (2016-2021) & ($ Millions)
Table 36. Europe Immuno-Oncology Market Size Market Share by Type (2016-2021)
Table 37. Europe Immuno-Oncology Market Size by Application (2016-2021) & ($ Millions)
Table 38. Europe Immuno-Oncology Market Size Market Share by Application (2016-2021)
Table 39. Middle East & Africa Immuno-Oncology Market Size by Region (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Immuno-Oncology Market Size Market Share by Region (2016-2021)
Table 41. Middle East & Africa Immuno-Oncology Market Size by Type (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Immuno-Oncology Market Size Market Share by Type (2016-2021)
Table 43. Middle East & Africa Immuno-Oncology Market Size by Application (2016-2021) & ($ Millions)
Table 44. Middle East & Africa Immuno-Oncology Market Size Market Share by Application (2016-2021)
Table 45. Key and Potential Regions of Immuno-Oncology
Table 46. Key Application and Potential Industries of Immuno-Oncology
Table 47. Key Challenges of Immuno-Oncology
Table 48. Key Trends of Immuno-Oncology
Table 49. Global Immuno-Oncology Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 50. Global Immuno-Oncology Market Size Market Share Forecast by Regions
Table 51. Global Immuno-Oncology Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 52. Global Immuno-Oncology Market Size Market Share Forecast by Type (2021-2026)
Table 53. Global Immuno-Oncology Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 54. Global Immuno-Oncology Market Size Market Share Forecast by Application (2021-2026)
Table 55. Bristol-Myers Squibb Details, Company Type, Immuno-Oncology Area Served and Its Competitors
Table 56. Bristol-Myers Squibb Immuno-Oncology Product Offered
Table 57. Bristol-Myers Squibb Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. Merck & Co., Inc. Details, Company Type, Immuno-Oncology Area Served and Its Competitors
Table 61. Merck & Co., Inc. Immuno-Oncology Product Offered
Table 62. Merck & Co., Inc. Main Business
Table 63. Merck & Co., Inc. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 64. Merck & Co., Inc. Latest Developments
Table 65. Roche AG Details, Company Type, Immuno-Oncology Area Served and Its Competitors
Table 66. Roche AG Immuno-Oncology Product Offered
Table 67. Roche AG Main Business
Table 68. Roche AG Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 69. Roche AG Latest Developments
Table 70. AstraZeneca, Plc Details, Company Type, Immuno-Oncology Area Served and Its Competitors
Table 71. AstraZeneca, Plc Immuno-Oncology Product Offered
Table 72. AstraZeneca, Plc Main Business
Table 73. AstraZeneca, Plc Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 74. AstraZeneca, Plc Latest Developments
Table 75. Sanofi S.A. Details, Company Type, Immuno-Oncology Area Served and Its Competitors
Table 76. Sanofi S.A. Immuno-Oncology Product Offered
Table 77. Sanofi S.A. Main Business
Table 78. Sanofi S.A. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 79. Sanofi S.A. Latest Developments
Table 80. Dendreon Pharmaceuticals Details, Company Type, Immuno-Oncology Area Served and Its Competitors
Table 81. Dendreon Pharmaceuticals Immuno-Oncology Product Offered
Table 82. Dendreon Pharmaceuticals Main Business
Table 83. Dendreon Pharmaceuticals Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 84. Dendreon Pharmaceuticals Latest Developments
Table 85. Novartis Details, Company Type, Immuno-Oncology Area Served and Its Competitors
Table 86. Novartis Immuno-Oncology Product Offered
Table 87. Novartis Main Business
Table 88. Novartis Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 89. Novartis Latest Developments
Table 90. Gilead Sciences Inc. Details, Company Type, Immuno-Oncology Area Served and Its Competitors
Table 91. Gilead Sciences Inc. Immuno-Oncology Product Offered
Table 92. Gilead Sciences Inc. Main Business
Table 93. Gilead Sciences Inc. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 94. Gilead Sciences Inc. Latest Developments
Table 95. Merck KGaA Details, Company Type, Immuno-Oncology Area Served and Its Competitors
Table 96. Merck KGaA Immuno-Oncology Product Offered
Table 97. Merck KGaA Main Business
Table 98. Merck KGaA Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 99. Merck KGaA Latest Developments
List of Figures
Figure 1. Immuno-Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-Oncology Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Immuno-Oncology Market Size Market Share by Type (2016-2021)
Figure 7. Immuno-Oncology in Hospitals
Figure 8. Global Immuno-Oncology Market: Hospitals (2016-2021) & ($ Millions)
Figure 9. Immuno-Oncology in Drugstores
Figure 10. Global Immuno-Oncology Market: Drugstores (2016-2021) & ($ Millions)
Figure 11. Immuno-Oncology in Others
Figure 12. Global Immuno-Oncology Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Immuno-Oncology Market Size Market Share by Application in 2020
Figure 14. Global Immuno-Oncology Revenue Market Share by Player in 2020
Figure 15. Global Immuno-Oncology Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Immuno-Oncology Market Size 2016-2021 ($ Millions)
Figure 17. APAC Immuno-Oncology Market Size 2016-2021 ($ Millions)
Figure 18. Europe Immuno-Oncology Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Immuno-Oncology Market Size 2016-2021 ($ Millions)
Figure 20. Americas Immuno-Oncology Market Size Market Share by Country in 2020
Figure 21. Americas Immuno-Oncology Market Size Market Share by Type in 2020
Figure 22. Americas Immuno-Oncology Market Size Market Share by Application in 2020
Figure 23. United States Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Immuno-Oncology Market Size Market Share by Regions in 2020
Figure 27. APAC Immuno-Oncology Market Size Market Share by Type in 2020
Figure 28. APAC Immuno-Oncology Market Size Market Share by Application in 2020
Figure 29. China Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Immuno-Oncology Market Size Market Share by Countries in 2020
Figure 36. Europe Immuno-Oncology Market Size Market Share by Type in 2020
Figure 37. Europe Immuno-Oncology Market Size Market Share by Application in 2020
Figure 38. Germany Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Immuno-Oncology Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Immuno-Oncology Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Immuno-Oncology Market Size Market Share by Application in 2020
Figure 46. Egypt Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Countries Immuno-Oncology Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 52. APAC Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 53. Europe Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 55. United States Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 56. Canada Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 59. China Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 60. Japan Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 61. Korea Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 63. India Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 64. Australia Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 65. Germany Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 66. France Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 67. UK Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 68. Italy Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 69. Russia Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 70. Spain Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 73. Israel Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Immuno-Oncology Market Size 2021-2026 ($ Millions)
Figure 75. GCC Countries Immuno-Oncology Market Size 2021-2026 ($ Millions)
Please feel free to write an email to us or to use our electronic ticketing system.
